Bristol-Myers Squibb Company and E.R. Squibb & Sons, Inc. v. Geneva Pharmaceuticals, Inc.
U.S. Court of Appeals for the Federal Circuit
Bristol-Myers Squibb Company and E.R. Squibb & Sons, Inc. v. Geneva Pharmaceuticals, Inc., 77 F.3d 502 (Fed. Cir. 1995)
1995 U.S. App. LEXIS 40970; 1995 WL 769042
Bristol-Myers Squibb Company and E.R. Squibb & Sons, Inc. v. Geneva Pharmaceuticals, Inc.
Opinion
77 F.3d 502
NOTICE: Federal Circuit Local Rule 47.6(b) states that opinions and orders which are designated as not citable as precedent shall not be employed or cited as precedent. This does not preclude assertion of issues of claim preclusion, issue preclusion, judicial estoppel, law of the case or the like based on a decision of the Court rendered in a nonprecedential opinion or order.
BRISTOL-MYERS SQUIBB COMPANY and E.R. Squibb & Sons, Inc.,
Plaintiffs-Appellants,
v.
GENEVA PHARMACEUTICALS, INC., Defendant-Appellee.
No. 96-1095.
United States Court of Appeals, Federal Circuit.
Dec. 21, 1995.
ORDER
The parties having so agreed, it is
1
ORDERED that the proceeding is DISMISSED under Fed.R.App.P. 42(b).
Reference
- Status
- Unpublished